RELB and neoplasm: In the case of ER-positive breast carcinoma, higher expression of RelB is associated with decreased relapse-free survival (RFS) and overall survival (OS) rate, whereas in other tumours, such as lung carcinoma, enhanced expression of NIK and RelB is associated with enhanced metastasis and shorter OS.